These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 37184402)
21. Nanodelivery of cGAS-STING activators for tumor immunotherapy. Guo J; Huang L Trends Pharmacol Sci; 2022 Nov; 43(11):957-972. PubMed ID: 36089410 [TBL] [Abstract][Full Text] [Related]
22. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment. Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541 [TBL] [Abstract][Full Text] [Related]
23. The pleiotropic roles of cGAS-STING signaling in the tumor microenvironment. Li J; Bakhoum SF J Mol Cell Biol; 2022 Aug; 14(4):. PubMed ID: 35325182 [TBL] [Abstract][Full Text] [Related]
24. Cancer Radiosensitization Nanoagent to Activate cGAS-STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy. Wu Z; Li Q; Zhu K; Zheng S; Hu H; Hou M; Qi L; Chen S; Xu Y; Zhao B; Yan C Adv Healthc Mater; 2024 Jun; 13(14):e2303626. PubMed ID: 38387885 [TBL] [Abstract][Full Text] [Related]
25. Tumor-derived nanovesicles enhance cancer synergistic chemo-immunotherapy by promoting cGAS/STING pathway activation and immunogenetic cell death. Guo Y; Qian R; Li Z; Lv T; Yang C; Li W; Pan T; Hou X; Wang Z Life Sci; 2024 Jul; 348():122687. PubMed ID: 38718856 [TBL] [Abstract][Full Text] [Related]
26. Simultaneous Photoactivation of cGAS-STING Pathway and Pyroptosis by Platinum(II) Triphenylamine Complexes for Cancer Immunotherapy. Ling YY; Xia XY; Hao L; Wang WJ; Zhang H; Liu LY; Liu W; Li ZY; Tan CP; Mao ZW Angew Chem Int Ed Engl; 2022 Oct; 61(43):e202210988. PubMed ID: 35979672 [TBL] [Abstract][Full Text] [Related]
27. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy. Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711 [TBL] [Abstract][Full Text] [Related]
28. Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Yu Y; Bogdan M; Noman MZ; Parpal S; Bartolini E; Van Moer K; Kleinendorst SC; Bilgrav Saether K; Trésaugues L; Silvander C; Lindström J; Simeon J; Timson MJ; Al-Hashimi H; Smith BD; Flynn DL; Alexeyenko A; Viklund J; Andersson M; Martinsson J; Pokrovskaja Tamm K; De Milito A; Janji B Mol Oncol; 2024 Aug; 18(8):1904-1922. PubMed ID: 38506049 [TBL] [Abstract][Full Text] [Related]
29. Ectopic expression of cGAS in Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345 [TBL] [Abstract][Full Text] [Related]
30. Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells. He Y; Yang Y; Huang W; Yang S; Xue X; Zhu K; Tan H; Sun T; Yang W Int J Radiat Biol; 2023; 99(12):1890-1907. PubMed ID: 37406172 [TBL] [Abstract][Full Text] [Related]
31. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation. Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380 [TBL] [Abstract][Full Text] [Related]
32. Tetrahedral DNA Nanostructure with Interferon Stimulatory DNA Delivers Highly Potent Toxins and Activates the cGAS-STING Pathway for Robust Chemotherapy and Immunotherapy. Zhang L; Wang Y; Karges J; Tang D; Zhang H; Zou K; Song J; Xiao H Adv Mater; 2023 Feb; 35(8):e2210267. PubMed ID: 36484099 [TBL] [Abstract][Full Text] [Related]
33. Napabucasin deactivates STAT3 and promotes mitoxantrone-mediated cGAS-STING activation for hepatocellular carcinoma chemo-immunotherapy. Wang L; Bi S; Li Z; Liao A; Li Y; Yang L; Zhou X; Gao Y; Liu X; Zou Y; Zhang X; Shi J; Yu S; Yu Z; Guo J Biomaterials; 2025 Feb; 313():122766. PubMed ID: 39180916 [TBL] [Abstract][Full Text] [Related]
34. The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer. Kwon J; Bakhoum SF Cancer Discov; 2020 Jan; 10(1):26-39. PubMed ID: 31852718 [TBL] [Abstract][Full Text] [Related]
35. The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy. Chen R; Liu M; Jiang Q; Meng X; Wei J Front Immunol; 2023; 14():1121603. PubMed ID: 37153627 [TBL] [Abstract][Full Text] [Related]
36. The cGAS/STING Pathway: A Novel Target for Cancer Therapy. Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W Front Immunol; 2021; 12():795401. PubMed ID: 35046953 [TBL] [Abstract][Full Text] [Related]
37. Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. Yan X; Yao C; Fang C; Han M; Gong C; Hu D; Shen W; Wang L; Li S; Zhu S Int J Biol Sci; 2022; 18(2):585-598. PubMed ID: 35002511 [No Abstract] [Full Text] [Related]
38. Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy. Song W; Song SJ; Kuang J; Yang H; Yu T; Yang F; Wan T; Xu Y; Wei ST; Li MX; Xiong Y; Zhou Y; Qiu WX ACS Nano; 2022 Oct; 16(10):15977-15993. PubMed ID: 36190834 [TBL] [Abstract][Full Text] [Related]
39. Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy. Yang L; Wang Y; Song Y; Li Z; Lei L; Li H; He B; Cao J; Gao H J Control Release; 2024 Jun; 370():354-366. PubMed ID: 38685387 [TBL] [Abstract][Full Text] [Related]
40. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies. Zhang J; Yu S; Peng Q; Wang P; Fang L Cancer Biol Med; 2024 Jan; 21(1):45-64. PubMed ID: 38172538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]